Published in Proc Natl Acad Sci U S A on January 01, 1976
Natural human antibodies reactive with primate type-C viral antigens. Proc Natl Acad Sci U S A (1977) 1.12
The occurrence and frequency of type C virus-like particles in placentas from patients with systemic lupus erythematosus and from normal subjects. Am J Pathol (1976) 1.09
Circulating immune complexes in systemic lupus erythematosus. Clin Exp Immunol (1977) 1.07
Autoimmune diseases: immunopathology and etiopathogenesis. Am J Pathol (1982) 1.07
Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents. Int J Clin Rheumtol (2011) 0.98
Selective up-regulation of intact, but not defective env RNAs of endogenous modified polytropic retrovirus by the Sgp3 locus of lupus-prone mice. J Immunol (2009) 0.98
Rauscher-leukemia-virus-related sequences in human DNA: presence in some tissues of some patients with hemotopoietic neoplasias and absence in DNA from other tissues. Proc Natl Acad Sci U S A (1977) 0.96
Clinical and immunological studies in a case of selective complete C1q deficiency. Clin Exp Immunol (1979) 0.88
Human antibodies reactive with purified envelope antigens of primate type C tumor viruses. Proc Natl Acad Sci U S A (1978) 0.88
Regional distribution of the enzymes of haem biosynthesis and the inhibition of 5-aminolaevulinate synthase by manganese in the rat brain. Biochem J (1980) 0.86
Type C RNA virus-specific antibody in human systemic lupus erythematosus demonstrated by enzymoimmunoassay. Proc Natl Acad Sci U S A (1978) 0.85
Type C oncornavirus isolation studies in systemic lupus erythematosus. II. Attempted detection by viral RNA-dependent DNA polymerase assay. Ann Rheum Dis (1978) 0.84
Evidence in patients with systemic lupus erythematosus of the presence of antibodies against RNA-dependent DNA polymerase of baboon endogenous virus. Clin Exp Immunol (1983) 0.82
Antibodies in human sera to oncorna virus-like proteins from normal or leukemia marrow cell cultures. J Exp Med (1976) 0.82
Detection and immunochemical characterization of a primate type C retrovirus-related p30 protein in normal human placentas. Proc Natl Acad Sci U S A (1984) 0.81
Immunohistologic detection of antigen related to primate type C retrovirus p30 in normal human placentas. Am J Pathol (1983) 0.81
Viruses and lymphocytes in rheumatoid arthritis. I. Studies on cultured rheumatoid lymphocytes. Ann Rheum Dis (1979) 0.80
T cells of lupus and molecular targets for immunotherapy. J Clin Immunol (1997) 0.76
Association of IL-10 Gene Polymorphisms and Human T Lymphotropic Virus Type I-Associated Myelopathy/tropical Spastic Paraparesis in North-East of Iran (Mashhad). Iran J Basic Med Sci (2013) 0.76
Viruses and lymphocytes in rheumatoid arthritis. II. Examination of lymphocytes and sera from patients with rheumatoid arthritis for evidence of retrovirus infection. Ann Rheum Dis (1979) 0.75
Is there any Association Between Human Lymphotropic Virus Type I (HTLV-I) Infection and Systemic Lupus Erythematosus? An Original Research and Literature Review. Iran J Basic Med Sci (2013) 0.75
Expression of antigenic crossreactivity to RD114 p 30 protein in a human fibrosarcoma cell line. Proc Natl Acad Sci U S A (1977) 0.75
Lupus nephritis class I accompanied by tubulointerstitial nephritis with marked T-lymphocyte infiltration in an HTLV-1 positive patient. CEN Case Rep (2012) 0.75
Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A (1969) 7.69
Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses. J Exp Med (1966) 6.45
Structural proteins of oncogenic ribonucleic acid viruses. Interspec II, a new interspecies antigen. J Biol Chem (1973) 5.05
Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction. J Exp Med (1957) 5.03
A proposed nomenclature for the virion proteins of oncogenic RNA viruses. Virology (1974) 5.01
Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature (1963) 4.66
SPECIFIC COMPLEMENT-FIXING VIRAL ANTIGENS IN HAMSTER AND GUINEA PIG TUMORS INDUCED BY THE SCHMIDT-RUPPIN STRAIN OF AVIAN SARCOMA. Proc Natl Acad Sci U S A (1964) 4.42
Structural proteins of mammalian oncogenic RNA viruses: multiple antigenic determinants of the major internal protein and envelope glycoprotein. J Virol (1974) 3.91
Group-specific antigen expression during embryogenesis of the genome of the C-type RNA tumor virus: implications for ontogenesis and oncogenesis. Proc Natl Acad Sci U S A (1970) 3.71
The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med (1974) 3.53
Detection of avian and mammalian oncogenic RNA viruses (oncornaviruses) by immunofluorescence. Cancer Res (1972) 3.23
RNA dependent DNA polymerase of human acute leukaemic cells. Nature (1970) 2.96
Radioimmunoassay of mammalian type-C viral proteins: interspecies antigenic reactivities of the major internal polypeptide. Proc Natl Acad Sci U S A (1972) 2.90
Immunological characterization of primate C-type virus reverse transcriptases. Nat New Biol (1972) 2.73
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. V. Identification of a new murine viral protein, p15(E). J Virol (1975) 2.72
Coexistence of intraspecies and interspecies specific antigenic determinants on the major structural polypeptide of mammalian C-type viruses. Nat New Biol (1971) 2.70
RNA in human leukemic cells related to the RNA of a mouse leukemia virus (leukocytes-RNA-DNA hybridization-rauscher virus-polysomal RNA). Proc Natl Acad Sci U S A (1972) 2.55
Wild-type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice. J Exp Med (1971) 2.41
Species-specific and interspecific antigenic determinants associated with the structural protein of feline C-type virus. Proc Natl Acad Sci U S A (1971) 2.20
Evolution of type C viral genes: I. Nucleic acid from baboon type C virus as a measure of divergence among primate species. Proc Natl Acad Sci U S A (1974) 2.03
Human sarcomas contain RNA related to the RNA of a mouse leukemia virus. Science (1972) 1.98
Properties of mouse leukemia viruses. VIII. The major viral glycoprotein of Friend leukemia virus. Seroimmunological, interfering and hemagglutinating capacities. Virology (1974) 1.98
Biological expression of antigenic determinants of murine leukemia virus proteins gp69-71 and p30. J Virol (1974) 1.95
Antibody to the RNA-dependent DNA polymerase of mammalian C-type RNA tumor viruses. Proc Natl Acad Sci U S A (1971) 1.86
Brief communication: C-type particles in normal human placentas. J Natl Cancer Inst (1973) 1.80
Shared group-specific antigen of murine and feline leukemia viruses. Virology (1968) 1.78
Interspecies antigenic determinants of the reverse transcriptases and p30 proteins of mammalian type C viruses. J Virol (1975) 1.64
Common cell surface antigen associated with mammalian C-type RNA viruses. Cell membrane-bound gs antigen. J Exp Med (1974) 1.61
Reverse transcriptases of primate viruses as immunological markers. Science (1972) 1.61
Amino acid sequence homology of mammalian type C RNA virus major internal proteins. J Biol Chem (1975) 1.51
Radioimmunoassay of the major group specific protein of endogenous baboon type C viruses: relation to the RD-114-CCC group and detection of antigen in normal baboon tissues. Virology (1974) 1.46
Expression of endogenous RNA C-type virus group-specific antigens in mammalian cells. J Virol (1973) 1.45
Radioimmunoassay of mammalian type-C polypeptides. IV. Characterization of woolly monkey and gibbon viral antigens. Int J Cancer (1973) 1.42
Isolation and characterization of two group-specific antigens from feline leukemia virus. Virology (1971) 1.41
Thymus dependence of cells in peripheral lymphoid tissues and in the circulation sensitive to natural thymocytotoxic autoantibody in NZB mice. J Immunol (1972) 1.32
Type-C RNA virus gene expression in human tissue. J Virol (1974) 1.26
Immune complex disease in the kidneys of lymphoma-leukemia patients: the presence of an oncornavirus-related antigen. J Natl Cancer Inst (1973) 1.23
Viral-related information in oncornavirus-lik particles isolated from cultures of marrow cells from leukemic patients in relapse and remission. Proc Natl Acad Sci U S A (1975) 1.20
C-type viruses in systemic lupus erythematosus. Nature (1974) 1.19
Primate type C virus p30 antigen in cells from humans with acute leukemia. Science (1975) 1.16
Structural proteins of mammalian RNA tumor viruses: relatedness of the interspecies antigenic determinants of the major internal protein. J Virol (1975) 1.06
Immunochemical studies of the major internal polypeptide of woolly monkey and gibbon ape type C viruses. J Immunol (1974) 1.03
Type C viral antigens in man. I. Antigens related to endogenous primate virus in human tumors. Proc Natl Acad Sci U S A (1974) 1.00
Radioimmunoassay for the major structural protein of hamster type C viruses. J Virol (1974) 0.96
Simultaneous purification of RNA-dependent DNA polymerase and gs-antigen from Rauscher leukemia virus. Biochem Biophys Res Commun (1975) 0.84
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med (1997) 10.62
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA (2000) 7.81
Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides. Antimicrob Agents Chemother (1993) 5.08
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci U S A (2009) 4.58
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. J Virol (1996) 4.45
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel. JAMA (1998) 4.42
Immunopathology of NZB/BL mice. V. Viruslike (filtrable) agent separable from lymphoma cells and identifiable by electron microscopy. J Exp Med (1966) 4.19
Further implication of murine leukemia-like virs in the disorders of NZB mice. J Exp Med (1969) 3.87
Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis (2000) 3.73
The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med (1974) 3.53
Natural thymocytotoxic autoantibody and reactive antigen in New Zealand black and other mice. Proc Natl Acad Sci U S A (1971) 3.50
Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. J Virol (2008) 2.56
Immunopathology of NZB/BL mice. VI. Virus separable from spleen and pathogenic for Swiss mice. J Exp Med (1967) 2.53
Autoimmune disease in NZB-Bl mice. II. Autoimmunity and malignant lymphoma. Blood (1966) 2.51
Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clin Infect Dis (2010) 2.51
Wild-type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice. J Exp Med (1971) 2.41
A recombinant retroviral system for rapid in vivo analysis of human immunodeficiency virus type 1 susceptibility to reverse transcriptase inhibitors. Antimicrob Agents Chemother (1997) 2.22
Autoimmune and immunoproliferative diseases of NZB/Bl mice and hybrids. Int Rev Exp Pathol (1966) 2.01
THE REGENERATIVE CYCLE OF MOTONEURONS, WITH SPECIAL REFERENCE TO PHOSPHATASE ACTIVITY. J Exp Med (1945) 1.97
Biological expression of antigenic determinants of murine leukemia virus proteins gp69-71 and p30. J Virol (1974) 1.95
A novel polymorphism at codon 333 of human immunodeficiency virus type 1 reverse transcriptase can facilitate dual resistance to zidovudine and L-2',3'-dideoxy-3'-thiacytidine. J Virol (1998) 1.92
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine. Ann Intern Med (2000) 1.88
A robust measure of HIV-1 population turnover within chronically infected individuals. Mol Biol Evol (2004) 1.87
Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study. AIDS (2001) 1.79
Common cell surface antigen associated with mammalian C-type RNA viruses. Cell membrane-bound gs antigen. J Exp Med (1974) 1.61
In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3'-azido-3'-deoxythymidine. Antimicrob Agents Chemother (2000) 1.60
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up. JAMA (1998) 1.59
Infrared Spectra of Tissues. Science (1949) 1.39
Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency. J Virol (2000) 1.38
CYTOCHROME OXIDASE IN NORMAL AND REGENERATING NEURONS. J Exp Med (1945) 1.37
Natural history of HIV-1 infection. Infect Dis Clin North Am (2000) 1.34
Natural cytotoxic autoantibody against thymocytes in NZB mice. Clin Exp Immunol (1972) 1.34
Thymus dependence of cells in peripheral lymphoid tissues and in the circulation sensitive to natural thymocytotoxic autoantibody in NZB mice. J Immunol (1972) 1.32
Changes in lymphoid populations of ageing CBA and NZB mice. Clin Exp Immunol (1971) 1.31
Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. J Infect Dis (1999) 1.28
Autoimmune disease in NZB/BL mice. 3. Induction of membranous glomerulonephritis in young mice by the transplantation of spleen cells from old mice. J Exp Med (1966) 1.24
Common cell-surface antigen associated with murine and feline C-type RNA leukemia viruses. Proc Natl Acad Sci U S A (1973) 1.20
HIV-1 viral dynamics and viral load measurement: implications for therapy. AIDS Clin Rev (1997) 1.20
Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance. Antimicrob Agents Chemother (2001) 1.16
Age-decrease of cells sensitive to an autoantibody-specific for thymocytes and thymus-dependent lymphocytes in NZB mice. Clin Exp Immunol (1972) 1.14
Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes. J Immunol (1987) 1.11
Wild-type Gross leukemia virus and heritable autoimmune disease of New Zealand mice. Am J Clin Pathol (1971) 1.09
The occurrence and frequency of type C virus-like particles in placentas from patients with systemic lupus erythematosus and from normal subjects. Am J Pathol (1976) 1.09
Granulocyte-macrophage colony-stimulating factor enhances selective effector functions of tissue-derived macrophages. Blood (1988) 1.09
Resistance of human immunodeficiency virus type 1 to acyclic 6-phenylselenenyl- and 6-phenylthiopyrimidines. Antimicrob Agents Chemother (1994) 1.08
Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol (1999) 1.07
Use of recombinant retroviruses to characterize the activity of antiretroviral compounds. J Virol (1991) 1.04
Stavudine resistance: an update on susceptibility following prolonged therapy. Antivir Ther (1999) 1.04
Arteriolization of venous blood gases: a clue to the diagnosis of cyanide poisoning. J Emerg Med (1989) 1.02
Murine leukemialike virus and the immunopathologic disorders of New Zealand black mice. J Infect Dis (1969) 1.00
IgG anti-cardiolipin antibodies in murine lupus. Clin Exp Immunol (1989) 0.99
Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group. Ann Intern Med (1997) 0.96
Assay and characterization of polyanion--immunoglobulin complexes in sera of New Zealand Black mice. Immunology (1974) 0.96
Effects of natural thymocytotoxic autoantibody of NZB mice and of specifically prepared antilymphocyte serum on the tissue distribution of 51 Cr-labeled lymphocytes. J Immunol (1973) 0.94
Electron microscopic study of distinctive structures in peripheral blood lymphocytes obtained from twins with systemic lupus erythematosus. Am J Pathol (1975) 0.93
HIV-1 viral load and clinical outcome: review of recent studies. AIDS (1997) 0.93
Recombinant retroviral systems for the analysis of drug resistant HIV. Nucleic Acids Res (1993) 0.92
The application of labeled antibody technics in studying cell antigens. Cancer Res (1968) 0.92
CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects. Clin Diagn Lab Immunol (2000) 0.91
A simple index to identify occult bacterial infection in adults with acute unexplained fever. Arch Intern Med (1987) 0.90
Pasteurella multocida septic arthritis. Conn Med (1984) 0.89
Immunologic observations on 9 sets of twins either concordant or discordant for SLE. Arthritis Rheum (1976) 0.89
Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples. Adv Virol (2011) 0.87
Prospects for the Biological Control of Cancer. Bull N Y Acad Med (1962) 0.86
Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults. Antivir Ther (2001) 0.86
The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview. Transfusion (1996) 0.86
Type C RNA virus-specific antibody in human systemic lupus erythematosus demonstrated by enzymoimmunoassay. Proc Natl Acad Sci U S A (1978) 0.85
Longitudinal patterns of HIV type 1 RNA among individuals with late disease progression. AIDS Res Hum Retroviruses (2001) 0.84
Antiretroviral activity of stavudine (2',3'-didehydro-3'-deoxythymidine, D4T). Antiviral Res (1995) 0.84
Biochemical characterization of HIV-1 reverse transcriptases encoding mutations at amino acid residues 161 and 208 involved in resistance to phosphonoformate. Biochem Pharmacol (1998) 0.83
Interleukin-6 expression in primary macrophages infected with human immunodeficiency virus-1 (HIV-1). AIDS Res Hum Retroviruses (1991) 0.83
Murine Type C viral envelope glycoprotein gp69/71 and lupus-like glomerulonephritis of New Zealand mice. An immunoperoxidase study. Am J Pathol (1977) 0.82
Effect of stavudine on human immunodeficiency virus type 1 virus load as measured by quantitative mononuclear cell culture, plasma RNA, and immune complex-dissociated antigenemia. J Infect Dis (1996) 0.82
Virologic, immunologic, and immune activation markers as predictors of HIV-associated weight loss prior to AIDS. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1999) 0.81
Immunohistologic detection of antigen related to primate type C retrovirus p30 in normal human placentas. Am J Pathol (1983) 0.81
Acute human immunodeficiency virus infection: false-negative ELISA in a patient with viremia and a positive western blot test. J Infect Dis (1989) 0.81
Detection and immunochemical characterization of a primate type C retrovirus-related p30 protein in normal human placentas. Proc Natl Acad Sci U S A (1984) 0.81
Impaired fitness of foscarnet-resistant strains of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1998) 0.80
Immunocytes and immunoglobulins. Blood (1966) 0.80
In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine. Antivir Chem Chemother (2000) 0.80
Value of the serum bactericidal test in management of patients with bacterial endocarditis. Eur J Clin Microbiol (1986) 0.80
Sanctuary growth of human immunodeficiency virus in the presence of 3'-azido-3'-deoxythymidine. J Virol (1995) 0.79
Tryptic peptide analysis of gag gene proteins of endogenous mouse type C viruses. J Virol (1979) 0.79
Adefovir for the treatment of HIV infection: if not now, when? JAMA (1999) 0.79
Pasteurella multocida prosthetic joint infection. Ann Emerg Med (1985) 0.78
Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 Infection. Adv Virol (2011) 0.78
Altered in vivo activity of liposome-incorporated lipopolysaccharide and lipid A. Infect Immun (1989) 0.77
Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro. Antimicrob Agents Chemother (1992) 0.77
Effective salvage therapy for HIV-1 infection--an unmet challenge. Antivir Ther (1999) 0.77
Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study Group. Ann Intern Med (1996) 0.77
Leukemia serum reactive with retrovirus-related antigen in normal human placenta. Int J Cancer (1986) 0.76
Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med (1985) 0.76
Diagnosis and treatment of urethritis in men. Yale J Biol Med (1983) 0.75
Bilateral otitis media and hearing loss in an adult. Yale J Biol Med (1986) 0.75
Safety and pharmacokinetics of 5-chloro-2',3'-dideoxy-3'-fluorouridine (935U83) following oral administration of escalating single doses in human immunodeficiency virus-infected adults. Antimicrob Agents Chemother (1996) 0.75